CrushSCI.com
47.6平均天数
48.5中位天数
27最短天数
66最长天数
1302025发文量

Paper Review Records

全部论文审稿周期

10 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期;保留 PDF/DOI/网页源链接

27 天

The role of the 21-gene assay in the neoadjuvant setting for hormone receptor-positive HER2-negative breast cancer: Impact on systemic and surgical treatment decisions

作者
Á.Guerrero Zotano; T.M. Allweis; R. Foerster; C. Palmieri; O. Gluz; S. Chia; C. Sotiriou; G. Bianchini展开收起
作者单位
Medical Oncology Department, Instituto Valenciano de Oncología, Valencia, Spain; GEICAM, Spanish Breast Cancer Group, Madrid, Spain; Dept. of Breast Surgery, Hadassah Medical Center, Jerusalem, Israel; Faculty of Medicine, Hebrew University, Jerusalem, Israel; Exact Sciences (Abbott Cancer Diagnostics), Baar, Zug, Switzerland; The Clatterbridge Cancer Centre NHS Foundation Trust, Liverpool, UK; University of Liverpool, Liverpool, UK; West German Study Group (WSG), Moenchengladbach, Germany; Breast Center Niederrhein, Ev. Hospital Bethesda, Moenchengladbach, Germany; University Clinics Cologne, Women’s Clinic and Breast Center, Cologne, Germany; Medical Oncology, British Columbia Cancer Agency, Vancouver, BC, Canada; Breast Cancer Translational Research Laboratory, Department of Medical Oncology, Institut Jules Bordet, Hôpital Universitaire de Bruxelles (H.U.B), Brussels, Belgium; Université Libre de Bruxelles (ULB), Brussels, Belgium; Medical Oncology Department, IRCCS San Raffaele Hospital, Milan, Italy; Vita-Salute San Raffaele University, Milan, Italy展开收起
PDF源文件 DOI 网页
62 天

Prognostic role of postoperative circulating tumor DNA in metastatic colorectal cancer treated with curative intent: A systematic review and meta-analysis

作者
Claudia Cardone; Sergio Facchini; Bruna de Oliveira Ascef; Antonino Cassata; Alfonso De Stefano; Paolo Chiodini; Antonio Avallone展开收起
作者单位
Experimental Clinical Abdominal Oncology Unit, Istituto Nazionale Tumori- IRCCS-Fondazione G. Pascale, Naples, Italy; Department of Mental and Physical Health and Preventive Medicine. Medical Statistics Unit. Università degli Studi della Campania Luigi Vanvitelli, Naples, Italy展开收起
PDF源文件 DOI 网页
64 天

Central nervous system and leptomeningeal metastases in patients with HER2-positive breast cancer: A comprehensive review and therapeutic algorithm proposal

作者
Aldo Caltavituro; Roberto Buonaiuto; Alessandra Longobardi; Paola Trasacco; Claudia Martinelli; Giuseppe Di Grazia; Roberto Pacelli; Grazia Arpino; Carmine De Angelis; Roberta Caputo; Michelino De Laurentiis; Elena Laakmann; Leonor Vasconcelos de Matos; Mário Fontes-Sousa; Mette van Ramshorst; Volkmar Mueller; Elisa Agostinetto; Sabine Linn; Michelangelo De Angelis; Francesco Schettini; Mario Giuliano展开收起
作者单位
Oncology Unit, Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy; Clinical and Translational Oncology, Scuola Superiore Meridionale, Naples, Italy; Translational Genomics and Targeted Therapies in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain; Department of Breast and Thoracic Oncology, Istituto Nazionale Tumori IRCCS “Fondazione G. Pascale”, Napoli, Italy; Department of Advanced Biomedical Sciences, University Federico II, Naples, Italy; University Medical Center Hamburg-Eppendorf, Department of Gynecology, Hamburg, Germany; Breast Cancer Unit, Champalimaud Clinical Centre, Champalimaud Foundation, Lisbon, Portugal; Oncology Unit, Hospital CUF Tejo, Lisbon, Portugal, Oncology Unit, Unidade Local de Saúde Lisboa Ocidental, Lisbon, Portugal; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands; Department of Gynecology, University Medical Center Hamburg 20246 Hamburg, Germany; Université libre de Bruxelles (ULB), Hôpital Universitaire de Bruxelles (H.U.B), Institut Jules Bordet, Bruxelles, Belgium; Department of Pathology, University Medical Center Utrecht, Utrecht, the Netherlands; IRCCS Istituto Neurologico Mediterraneo Neuromed, Division of Neurosurgery, Isernia, Italy; Clinic Barcelona Comprehensive Cancer Center, Hospital Clinic of Barcelona, Barcelona, Spain; Faculty of Medicine and Health Sciences, University of Barcelona, Barcelona, Spain展开收起
PDF源文件 DOI 网页
37 天

KRAS G12C-mutant non-small cell lung cancer: A practical guide for clinicians

作者
Jordi Remon; Giulia La-Cava; Maxime Borgeaud; Stephanie P.L. Saw; Lizza EL Hendriks; Biagio Ricciuti展开收起
作者单位
Department of Medical Oncology, Thoracic Group, Gustave Roussy, Villejuif, France; Paris-Saclay University, Paris, France; Department of Medicine and Surgery, University Campus Bio-Medico of Rome, Rome, Italy; Oncology Department, University Hospital Geneva, Geneva, Switzerland; Division of Medical Oncology, National Cancer Centre Singapore, Singapore; Department of Pulmonary Diseases, Maastricht University Medical Centre (+), GROW Research Institute for Oncology and Reproduction, Maastricht, the Netherlands; Lowe Center of Thoracic Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, United States展开收起
PDF源文件 DOI 网页
32 天

Circulating tumor DNA for predicting recurrence and mortality in patients with resected Melanoma: A systematic review and meta-analysis

作者
Pedro C. Abrahão Reis; Mariana Macambira Noronha; João Pedro Oliveira; João Evangelista Ponte Conrado; Isabella Romagnoli Buonopane; Carlos Diego Holanda Lopes; Daniel V. Araujo; Erick F. Saldanha展开收起
作者单位
Universidade Federal do Rio de Janeiro (UFRJ), RJ, Brazil; Universidade Federal do Ceará (UFC), CE, Brazil; Universidade Federal da Bahia (UFBA), BA, Brazil; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, ON, Canada; Department of Medicine, University of Toronto, ON, Canada; University of Florida, Gainesville, FL, USA; Harvard T. H. Chan School of Public Health, Harvard University, MA, USA展开收起
PDF源文件 DOI 网页
57 天

Targeting key epigenetic regulators in solid tumors: focus on EZH2, PRMT5, and BET inhibitors

作者
Irene Hernández de Córdoba Sánchez; Mercedes Avedillo Ruidiaz; Victor Moreno; Henry Long; Paloma Cejas展开收起
作者单位
Department of Medical Oncology, University Hospital Infanta Sofía, San Sebastián de los Reyes, 28702 Madrid, Spain; Department of Medical Oncology, University Hospital Fundación Jiménez Díaz, Moncloa-Aravaca, 28040 Madrid, Spain; START Madrid-FJD Early Phase Clinical Trials Unit, University Hospital Fundación Jiménez Díaz, 28040 Madrid, Spain; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA 02215, USA展开收起
PDF源文件 DOI 网页

FAQ

CANCER TREATMENT REVIEWS审稿要多久?

截至2026-11-19,CrushSCI 收录了 CANCER TREATMENT REVIEWS 的 10 篇完整审稿记录。最快一篇从收稿到录用用了 27 天(The role of the 21-gene assay in the neoadjuvant setting for hormone receptor-positive HER2-negative breast cancer: Impact on systemic and surgical treatment decisions,2026-04-28 收稿,2026-05-25 录用),最慢一篇用了 66 天;平均 47.6 天,中位数 48.5 天。

Expert Matching · Case Demo

把投稿要求,转成可验证的期刊方案

说清专业、时限和作者背景,CrushSCI 结合真实审稿样本,给出拟题方向、期刊初筛与周期判断。

我们会在半小时内回复。

CrushSCI 在线

客户询问

我是环境工程专业,需要一篇 SCI,希望 3 个月内见刊。没有基金,也没有大牛挂名,可以投哪些期刊?

CrushSCI回复

可以。先按 90 天时限做可行性筛选,同步查找无基金、无知名作者挂靠的典型论文案例,作为选刊依据。重点核对研究质量与期刊 scope。

拟题建议
《融合机器学习与生命周期评价的城市污水处理碳排放预测与优化》

样本口径2026 年最近 5 篇有效论文样本

平均审稿59.6 天

中位数65 天

Contact CrushSCI

联系 CrushSCI

留下手机号或微信号,我们将与你确认学术润色、结构优化或一对一辅导咨询需求。

我们会在半小时内回复。

当前选择:学术咨询服务

预留联系方式

也可以直接发送邮件至 leader@crushsci.com

手机号和微信号至少填写一项,仅用于本次咨询联系,不会公开。